An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

NCT00322127 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: AMD3100

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)